IMMUNOVANT INC

Ticker: IMVT CUSIP: 45258J102 Class: Common Stock

MARSHALL WACE, LLP's Holding History (CIK: 0001318757)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025
Shares 419,680 Value ($000) $6,765 Avg Close $16.19 Range $14.32 - $19.06
Q1 2025
Shares 138,477 Value ($000) $2,367 Avg Close $20.92 Range $16.72 - $25.79
Q3 2024
Shares 114,104 Value ($000) $3,253 Avg Close $29.49 Range $25.78 - $34.47
Q1 2024
Shares 53,533 Value ($000) $1,730 Avg Close $36.48 Range $29.71 - $45.58
Q3 2023
Shares 5,900 Value ($000) $227 Avg Close $22.60 Range $18.16 - $44.19
Q4 2022
Shares 38,953 Value ($000) $691 Avg Close $12.59 Range $5.48 - $17.90
Q4 2021
Shares 8,316 Value ($000) $71 Avg Close $8.26 Range $7.13 - $9.54
Q3 2021
Shares 72,822 Value ($000) $633 Avg Close $9.02 Range $6.68 - $11.38
Q2 2021
Shares 17,167 Value ($000) $181 Avg Close $13.96 Range $9.22 - $17.20
Q1 2021
Shares 21,194 Value ($000) $340 Avg Close $26.37 Range $11.80 - $50.32
Q4 2020
Shares 5,455 Value ($000) $252 Avg Close $46.23 Range $34.71 - $53.75
Q2 2020
Shares 63,511 Value ($000) $1,546 Avg Close $21.43 Range $13.30 - $29.96
Q1 2020
Shares 11,036 Value ($000) $172 Avg Close $15.04 Range $8.34 - $18.69